Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1978 Sep;188(3):271–280. doi: 10.1097/00000658-197809000-00002

A Randomized, Controlled Trial of the Distal Splenorenal Shunt

Layton F Rikkers, Daniel Rudman, John T Galambos, J Timothy Fulenwider, William J Millikan, Michael Kutner, Robert B Smith III, Atef A Salamn, Peter J Jones Jr, W Dean Warren
PMCID: PMC1396989  PMID: 308357

Abstract

In 1971 a prospective, randomized trial was initiated to determine efficacy of the distal splenorenal shunt in the management of cirrhotic patients who had previously bled from esophageal varices. When entry into the trial was terminated in 1976, 26 patients had received the distal splenorenal shunt (selective) and 29 had undergone a nonselective shunting procedure (18 interposition mesorenal, six interposition mesocaval, and five other nonselective shunts). Three operative deaths occurred in each group. Early postoperative angiography revealed preservation of hepatic portal perfusion in 14 of 16 selective patients (88%), but in only one of 20 nonselective patients (5%; p < .001). Quantitative measures of hepatic function (maximal rate of urea synthesis or MRUS and Child's score) were similar to preoperative values in the selective group but were significantly decreased in nonselective patients on the first postoperative evaluation (p < .001 for MRUS; p < .05 for Child's score). Eighty-seven per cent of selective and 81% of nonselective patients have now been followed for three to six years since surgery. Late postoperative evaluation of 29 survivors (12 selective, 17 nonselective) still shows an advantage to the selective group with respect to MRUS, Child's score, and incidence of hepatopetal portal blood flow, but differences are no longer statistically significant. However, if the seven patients with portal flow (five selective; two nonselective) are compared to the 20 with absent portal flow (seven selective; 13 nonselective), the former group has significantly higher values for MRUS (p < .05) and Child's score (p < .025). No patient with continuing portal perfusion has developed encephalopathy as compared to a 45% incidence of this complication in individuals without portal flow (p < .05). No significant differences between selective and nonselective groups have appeared with respect to total cumulative mortality (ten selective; 38%; eight nonselective, 28%), shunt occlusion (two selective, 10%; five nonselective, 18%), or recurrent variceal hemorrhage (one selective, 4%; two nonselective, 8%). Overall, significantly fewer selective patients have developed postoperative encephalopathy (three selective, 12%; 15 nonselective, 52%; p < .001). Therefore, we conclude that the distal splenorenal shunt, especially when its objective of maintaining hepatic portal perfusion is achieved, results in significantly less morbidity than nonselective shunting procedures.

Full text

PDF
271

Images in this article

277Figs. 2a and b.
on p.277
278Figs. 3a and b.
on p.278

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell D. P., Parker D. E., Anagnostopoulos C. E. Survival prediction in portacaval shunts: a computerized statistical analysis. Am J Surg. 1973 Dec;126(6):748–751. doi: 10.1016/s0002-9610(73)80062-5. [DOI] [PubMed] [Google Scholar]
  2. Drapanas T., LoCicero J., 3rd, Dowling J. B. Hemodynamics of the interposition mesocaval shunt. Ann Surg. 1975 May;181(5):523–533. doi: 10.1097/00000658-197505000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fisher B., Szuch P., Fisher E. R. Evaluation of a humoral factor in liver regeneration utilizing liver transplants. Cancer Res. 1971 Mar;31(3):322–331. [PubMed] [Google Scholar]
  4. Galambos J. T., Warren W. D., Rudman D., Smith R. B., 3rd, Salam A. A. Selective and total shunts in the treatment of bleeding varices. A randomized controlled trial. N Engl J Med. 1976 Nov 11;295(20):1089–1095. doi: 10.1056/NEJM197611112952001. [DOI] [PubMed] [Google Scholar]
  5. Gerron G. G., Ansley J. D., Isaacs J. W., Kutner M. H., Rudman D. Technical pitfalls in measurement of venous plasma NH3 concentration. Clin Chem. 1976 May;22(5):663–666. [PubMed] [Google Scholar]
  6. Jackson F. C., Perrin E. B., Felix W. R., Smith A. G. A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation. Ann Surg. 1971 Oct;174(4):672–701. doi: 10.1097/00000658-197110000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Marchioro T. L., Porter K. A., Brown B. I., Otte J. B., Starzl T. E. The effect of partial portacaval transposition on the canine liver. Surgery. 1967 May;61(5):723–732. [PMC free article] [PubMed] [Google Scholar]
  8. Mikkelsen W. P. Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis. Arch Surg. 1974 Mar;108(3):302–305. doi: 10.1001/archsurg.1974.01350270036007. [DOI] [PubMed] [Google Scholar]
  9. Mutchnick M. G., Lerner E., Conn H. O. Portal-systemic encephalopathy and portacaval anastomosis: a prospective, controlled investigation. Gastroenterology. 1974 May;66(5):1005–1019. [PubMed] [Google Scholar]
  10. Nabseth D. C., Widrich W. C., O'Hara E. T., Johnson W. C. Flow and pressure characteristics of the portal system before and after splenorenal shunts. Surgery. 1975 Dec;78(6):739–748. [PubMed] [Google Scholar]
  11. PARSONS-SMITH B. G., SUMMERSKILL W. H., DAWSON A. M., SHERLOCK S. The electroencephalograph in liver disease. Lancet. 1957 Nov 2;273(7001):867–871. doi: 10.1016/s0140-6736(57)90005-3. [DOI] [PubMed] [Google Scholar]
  12. Resnick R. H., Iber F. L., Ishihara A. M., Chalmers T. C., Zimmerman H. A controlled study of the therapeutic portacaval shunt. Gastroenterology. 1974 Nov;67(5):843–857. [PubMed] [Google Scholar]
  13. Rudman D., DiFulco T. J., Galambos J. T., Smith R. B., 3rd, Salam A. A., Warren W. D. Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest. 1973 Sep;52(9):2241–2249. doi: 10.1172/JCI107410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rueff B., Prandi D., Degos F., Sicot J., Degos J. D., Sicot C., Maillard J. N., Fauvert R., Benhamou J. P. A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis. Lancet. 1976 Mar 27;1(7961):655–659. doi: 10.1016/s0140-6736(76)92775-6. [DOI] [PubMed] [Google Scholar]
  15. Schenker S., Breen K. J., Hoyumpa A. M., Jr Hepatic encephalopathy: current status. Gastroenterology. 1974 Jan;66(1):121–151. [PubMed] [Google Scholar]
  16. Starzl T. E., Francavilla A., Halgrimson C. G., Francavilla F. R., Porter K. A., Brown T. H., Putnam C. W. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet. 1973 Aug;137(2):179–199. [PMC free article] [PubMed] [Google Scholar]
  17. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl. 1966;18:118–125. [PubMed] [Google Scholar]
  18. Vang J., Simert G., Hansson J. A., Thylen U., Bengmark T. S. Results of a modified distal spleno-renal shunt for portal hypertension. Ann Surg. 1977 Feb;185(2):224–228. doi: 10.1097/00000658-197702000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Warren W. D., Salam A. A., Hutson D., Zeppa R. Selective distal splenorenal shunt. Technique and results of operation. Arch Surg. 1974 Mar;108(3):306–314. doi: 10.1001/archsurg.1974.01350270040008. [DOI] [PubMed] [Google Scholar]
  20. Warren W. D., Zeppa R., Fomon J. J. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg. 1967 Sep;166(3):437–455. doi: 10.1097/00000658-196709000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES